{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:15:23Z","timestamp":1780078523110,"version":"3.54.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s40266-014-0184-2","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T10:02:02Z","timestamp":1399975322000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Medication Use Before and After Hip Fracture: A Population-Based Cohort and Case-Control Study"],"prefix":"10.1007","volume":"31","author":[{"given":"Maurizio","family":"Rossini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Buda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Degli Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"key":"184_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.","journal-title":"Arch Osteoporos"},{"key":"184_CR2","first-page":"97","volume":"57","author":"M Rossini","year":"2005","unstructured":"Rossini M, Piscitelli P, Fitto F, et al. Incidence and socioeconomic burden of hip fractures in Italy. Reumatismo. 2005;57:97\u2013102.","journal-title":"Reumatismo"},{"key":"184_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00198-006-0224-9","volume":"18","author":"P Piscitelli","year":"2007","unstructured":"Piscitelli P, Iolascon G, Gimigliano F, et al. Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int. 2007;18:211\u20139.","journal-title":"Osteoporos Int"},{"key":"184_CR4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ageing\/afq044","volume":"39","author":"JA Stevens","year":"2010","unstructured":"Stevens JA, Anne Rudd R. Declining hip fracture rates in the United States. Age Ageing. 2010;39:500\u20133.","journal-title":"Age Ageing"},{"key":"184_CR5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-009-1084-x","volume":"21","author":"P Piscitelli","year":"2010","unstructured":"Piscitelli P, Gimigliano F, Gatto S, et al. Hip fractures in Italy: 2000\u20132005 extension study. Osteoporos Int. 2010;21:1323\u201330.","journal-title":"Osteoporos Int"},{"key":"184_CR6","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Oden A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239\u201356.","journal-title":"Osteoporos Int"},{"key":"184_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-012-9666-6","volume":"92","author":"A Oden","year":"2013","unstructured":"Oden A, McCloskey EV, Johansson H, et al. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2013;92:42\u20139.","journal-title":"Calcif Tissue Int"},{"key":"184_CR8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/bmj.323.7316.795","volume":"323","author":"TJ Wilkin","year":"2001","unstructured":"Wilkin TJ, Devendra D. Bone densitometry is not a good predictor of hip fracture. BMJ. 2001;323:795\u20139.","journal-title":"BMJ"},{"key":"184_CR9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bone.2004.11.012","volume":"36","author":"S Kaptoge","year":"2005","unstructured":"Kaptoge S, Benevolenskaya LI, Bhalla AK, et al. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. Bone. 2005;36:387\u201398.","journal-title":"Bone"},{"key":"184_CR10","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/jc.2004-1568","volume":"90","author":"SA Wainwright","year":"2005","unstructured":"Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis J Clin Endocrinol Metab. 2005;90:2787\u201393.","journal-title":"Hip fracture in women without osteoporosis J Clin Endocrinol Metab"},{"key":"184_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bone.2012.11.006","volume":"52","author":"MH Edwards","year":"2013","unstructured":"Edwards MH, Jameson K, Denison H, et al. Clinically risk factors, bone density and fall history in the prediction of incident fracture among men and women. Bone. 2013;52:541\u20137.","journal-title":"Bone"},{"key":"184_CR12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/PL00004184","volume":"12","author":"TS Wei","year":"2001","unstructured":"Wei TS, Hu CH, Wang SH, et al. Fall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly. Osteoporos Int. 2001;12:1050\u20135.","journal-title":"Osteoporos Int"},{"key":"184_CR13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1532-5415.1997.tb05975.x","volume":"45","author":"R Norton","year":"1997","unstructured":"Norton R, Campbell J, Lee-Joe T, et al. Circumstances of falls resulting in hip fractures among older people. J Am Geriatr Soc. 1997;45:1108\u201312.","journal-title":"J Am Geriatr Soc"},{"key":"184_CR14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581\u20139.","journal-title":"Osteoporos Int"},{"key":"184_CR15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","volume":"50","author":"EM Dennison","year":"2012","unstructured":"Dennison EM, Compston JE, Flahive J, et al. Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2012;50:1288\u201393.","journal-title":"Bone"},{"key":"184_CR16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/bmj.327.7417.712","volume":"327","author":"DA Lawlor","year":"2003","unstructured":"Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ. 2003;327:712.","journal-title":"BMJ"},{"key":"184_CR17","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1001\/jama.2009.1738","volume":"302","author":"SG Leveille","year":"2009","unstructured":"Leveille SG, Jones RN, Kiely DK, et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA. 2009;302:2214\u201321.","journal-title":"JAMA"},{"key":"184_CR18","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1378\/chest.07-1092","volume":"132","author":"R Vestergaard","year":"2007","unstructured":"Vestergaard R, Rejnmark L, Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest. 2007;132:1599\u2013607.","journal-title":"Chest"},{"key":"184_CR19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/annrheumdis-2012-201451","volume":"72","author":"D Prieto-Alhambra","year":"2013","unstructured":"Prieto-Alhambra D, Nogues X, Javaid MK, et al. An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Ann Rheum Dis. 2013;72:911\u20137.","journal-title":"Ann Rheum Dis"},{"key":"184_CR20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","volume":"29","author":"M Janghorbani","year":"2006","unstructured":"Janghorbani M, Feskanich D, Willett WC, et al. Prospective study of diabetes and risk of hip fracture: the Nurses\u2019 Health Study. Diabetes Care. 2006;29:1573\u20138.","journal-title":"Diabetes Care"},{"key":"184_CR21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.5694\/j.1326-5377.1993.tb121839.x","volume":"158","author":"RG Cumming","year":"1993","unstructured":"Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust. 1993;158:414\u20137.","journal-title":"Med J Aust"},{"key":"184_CR22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","volume":"17","author":"RG Cumming","year":"2003","unstructured":"Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17:825\u201337.","journal-title":"CNS Drugs"},{"key":"184_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","volume":"47","author":"RM Leipzig","year":"1999","unstructured":"Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"184_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","volume":"47","author":"RM Leipzig","year":"1999","unstructured":"Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47:30\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"184_CR25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00198-008-0748-2","volume":"20","author":"E Barrett-Connor","year":"2009","unstructured":"Barrett-Connor E, Weiss TW, McHorney CA, et al. Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2009;20:715\u201322.","journal-title":"Osteoporos Int"},{"key":"184_CR26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(03)12502-0","volume":"361","author":"JG Evans","year":"2003","unstructured":"Evans JG. Drugs and falls in later life. Lancet. 2003;361:448.","journal-title":"Lancet"},{"key":"184_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/pds.686","volume":"11","author":"CI Neutel","year":"2002","unstructured":"Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf. 2002;11:97\u2013104.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"184_CR28","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcoot","year":"2009","unstructured":"Woolcoot JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 classes on falls in elderly persons. Arch Intern Med. 2009;169:1952\u201360.","journal-title":"Arch Intern Med"},{"key":"184_CR29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002512-200926050-00002","volume":"26","author":"A Darowsky","year":"2009","unstructured":"Darowsky A, Chambers SACF, Chambers DJ. Antidepressants and falls in the elderly. Drugs Aging. 2009;26:381\u201394.","journal-title":"Drugs Aging"},{"key":"184_CR30","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00198-009-0849-6","volume":"20","author":"MW Brand van den","year":"2009","unstructured":"van den Brand MW, Pouwels S, Samson MM, et al. Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int. 2009;20:1705\u201313.","journal-title":"Osteoporos Int"},{"key":"184_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archinternmed.2008.526","volume":"169","author":"LD Carbone","year":"2009","unstructured":"Carbone LD, Johnson KC, Bush AJ, et al. Loop diuretic use and fracture in postmenopausal women: findings from the Women\u2019s Health Initiative. Arch Intern Med. 2009;169:132\u201340.","journal-title":"Arch Intern Med"},{"key":"184_CR32","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00198-008-0826-5","volume":"20","author":"S Pouwels","year":"2009","unstructured":"Pouwels S, van Staa TP, Egberts AC, et al. Antipsychotic use and the risk of hip\/femur fracture: a population-based case\u2013control study. Osteoporos Int. 2009;20:1499\u2013506.","journal-title":"Osteoporos Int"},{"key":"184_CR33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1359\/jbmr.091027","volume":"25","author":"LD Carbone","year":"2010","unstructured":"Carbone LD, Johnson KC, Robbins J, et al. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women\u2019s health initiative (WHI). J Bone Miner Res. 2010;25:873\u201381.","journal-title":"J Bone Miner Res"},{"key":"184_CR34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1592\/phco.30.7.716","volume":"30","author":"DM Riche","year":"2010","unstructured":"Riche DM. Travis King S. Bone loss and fracture risk associated with thiazolidinedione therapy. Pharmacotherapy. 2010;30:716\u201327.","journal-title":"Pharmacotherapy"},{"key":"184_CR35","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/jc.2009-2342","volume":"95","author":"S Pouwels","year":"2010","unstructured":"Pouwels S, Lalmohamed A, van Staa T, et al. Use of organic nitrates and the risk of hip fracture: a population-based case-control study. J Clin Endocrinol Metab. 2010;95:1924\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"184_CR36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-010-1337-8","volume":"22","author":"S Pouwels","year":"2011","unstructured":"Pouwels S, Lalmohamed A, Souverein P, et al. Use of proton pump inhibitors and risk of hip\/femur fracture: a population-based case-control study. Osteoporos Int. 2011;22:903\u201310.","journal-title":"Osteoporos Int"},{"key":"184_CR37","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, et al. Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res. 2011;26:1561\u20137.","journal-title":"J Bone Miner Res"},{"key":"184_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bone.2010.10.170","volume":"48","author":"S Yang","year":"2011","unstructured":"Yang S, Nguyen ND, Center JR, et al. Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone. 2011;48:451\u20135.","journal-title":"Bone"},{"key":"184_CR39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","volume":"48","author":"CS Kwok","year":"2011","unstructured":"Kwok CS, Yeong JKY, Loke YK. Meta-analysis: risk of fractures with acid-suppressing medication. Bone. 2011;48:768\u201376.","journal-title":"Bone"},{"key":"184_CR40","first-page":"998","volume":"171","author":"B Abrahamsen","year":"2011","unstructured":"Abrahamsen B, Eiken P, Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med. 2011;171:998\u20131004.","journal-title":"Arch Intern Med"},{"key":"184_CR41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00223-011-9481-5","volume":"88","author":"SJ Diem","year":"2011","unstructured":"Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressant medications and risk of fracture in older women. Calcif Tissue Int. 2011;88:476\u201384.","journal-title":"Calcif Tissue Int"},{"key":"184_CR42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1532-5415.2011.03318.x","volume":"59","author":"M Miller","year":"2011","unstructured":"Miller M, St\u00fcrmer T, Azrael D, et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59:430\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"184_CR43","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00198-010-1455-3","volume":"22","author":"ME Arbouw","year":"2011","unstructured":"Arbouw ME, Movig KL, van Staa TP, et al. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int. 2011;22:2197\u2013204.","journal-title":"Osteoporos Int"},{"key":"184_CR44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/jbmr.1813","volume":"28","author":"Q Wu","year":"2013","unstructured":"Wu Q, Qu W, Crowell MD, et al. Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies. J Bone Miner Res. 2013;28:753\u201363.","journal-title":"J Bone Miner Res"},{"key":"184_CR45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-011-1778-8","volume":"23","author":"Q Wu","year":"2012","unstructured":"Wu Q, Bencaz AF, Hentz JG, et al. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int. 2012;23:365\u201375.","journal-title":"Osteoporos Int"},{"key":"184_CR46","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","volume":"27","author":"CS Eom","year":"2012","unstructured":"Eom CS, Lee HK, Ye S, et al. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J Bone Miner Res. 2012;27:1186\u201395.","journal-title":"J Bone Miner Res"},{"key":"184_CR47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bone.2012.07.030","volume":"51","author":"V Rabenda","year":"2012","unstructured":"Rabenda V, Bruy\u00e8re O, Reginster JY. Risk of non vertebral fractures among elderly postmenopausal women using antidepressants. Bone. 2012;51:674\u20139.","journal-title":"Bone"},{"key":"184_CR48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00198-012-2043-5","volume":"24","author":"P Vestergaard","year":"2013","unstructured":"Vestergaard P, Preto-Alhambra D, Javaid MK, et al. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos Int. 2013;24:671\u201380.","journal-title":"Osteoporos Int"},{"key":"184_CR49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00223-012-9603-8","volume":"91","author":"TP Khong","year":"2012","unstructured":"Khong TP, de Vries F, Goldenberg JS, et al. Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States. Calcif Tissue Int. 2012;91:24\u201331.","journal-title":"Calcif Tissue Int"},{"key":"184_CR50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1370\/afm.1243","volume":"9","author":"CS Eom","year":"2011","unstructured":"Eom CS, Park SM, Myung SK, et al. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med. 2011;9:257\u201367.","journal-title":"Ann Fam Med"},{"key":"184_CR51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-012-2112-9","volume":"24","author":"LA Fraser","year":"2013","unstructured":"Fraser LA, Leslie WD, Targownik LE, et al. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int. 2013;24:1161\u20138.","journal-title":"Osteoporos Int"},{"key":"184_CR52","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","volume":"23","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Hermann P, Jensen JE, et al. Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int. 2012;23:1255\u201365.","journal-title":"Osteoporos Int"},{"key":"184_CR53","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bone.2011.03.435","volume":"48","author":"LJ Williams","year":"2011","unstructured":"Williams LJ, Pasco JA, Henry MJ, et al. Paracetamol (acetaminophen) use, fracture and bone mineral density. Bone. 2011;48:1277\u201381.","journal-title":"Bone"},{"key":"184_CR54","first-page":"89","volume":"12","author":"L Degli Esposti","year":"2011","unstructured":"Degli Esposti L, Adami S, Iolascon G, et al. Il costo delle fratture da osteoporosi in Italia. Risultati dello studio BLOCK (Bone Loss and Osteoporosis: Cost-of-illness Knowledge). Farmeconomia e Percorsi Terapeutici. 2011;12:89\u201395.","journal-title":"Farmeconomia e Percorsi Terapeutici"},{"key":"184_CR55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0149-2918(97)80122-1","volume":"19","author":"BR Motheral","year":"1997","unstructured":"Motheral BR, Fairman KA. The use of claims databases for outcomes research: rationale, challenges, and strategies. Clin Ther. 1997;19:346\u201366.","journal-title":"Clin Ther"},{"key":"184_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199916010-00001","volume":"16","author":"HG Birnbaum","year":"1999","unstructured":"Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcome research and pharmacoeconomic analyses. Pharmacoeconomics. 1999;16:1\u20138.","journal-title":"Pharmacoeconomics"},{"key":"184_CR57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1041-2972.2005.0020.x","volume":"17","author":"MM Fulton","year":"2005","unstructured":"Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17:123\u201332.","journal-title":"J Am Acad Nurse Pract"},{"key":"184_CR58","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1359\/jbmr.091029","volume":"25","author":"ID Cameron","year":"2010","unstructured":"Cameron ID, Chen JS, March LM, et al. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J Bone Miner Res. 2010;25:866\u201372.","journal-title":"J Bone Miner Res"},{"key":"184_CR59","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","volume":"16","author":"C Laet De","year":"2005","unstructured":"De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330\u20138.","journal-title":"Osteoporos Int"},{"key":"184_CR60","doi-asserted-by":"crossref","first-page":"e55077","DOI":"10.1371\/journal.pone.0055077","volume":"8","author":"X Tang","year":"2013","unstructured":"Tang X, Liu G, Kang J, et al. Obesity and risk of hip fracture in adults: a meta-analysis of prospective cohort studies. PLoS One. 2013;8:e55077.","journal-title":"PLoS One"},{"key":"184_CR61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00198-008-0651-x","volume":"20","author":"C Roerholt","year":"2009","unstructured":"Roerholt C, Eiken P, Abrahamsen B. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int. 2009;20:299\u2013307.","journal-title":"Osteoporos Int"},{"key":"184_CR62","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00198-011-1630-1","volume":"23","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Giangregorio LM, Yogendran M, et al. A population-based analysis of the post-fracture care gap 1996\u20132008: the situation is not improving. Osteoporos Int. 2012;23:1623\u20139.","journal-title":"Osteoporos Int"},{"key":"184_CR63","first-page":"260","volume":"61","author":"S Adami","year":"2009","unstructured":"Adami S, Bertoldo F, Brandi ML, et al. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo. 2009;61:260\u201384.","journal-title":"Reumatismo"},{"key":"184_CR64","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00198-005-2026-x","volume":"17","author":"S Helden van","year":"2006","unstructured":"van Helden S, Cals J, Kessels F, et al. Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int. 2006;17:348\u201354.","journal-title":"Osteoporos Int"},{"key":"184_CR65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.297.4.387","volume":"297","author":"JR Center","year":"2007","unstructured":"Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007;297:387\u201394.","journal-title":"JAMA"},{"key":"184_CR66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00198-006-0274-z","volume":"18","author":"SL Silverman","year":"2007","unstructured":"Silverman SL, Watts NB, Delmas PD, et al. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int. 2007;18:25\u201334.","journal-title":"Osteoporos Int"},{"key":"184_CR67","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bone.2009.01.002","volume":"44","author":"ST Harris","year":"2009","unstructured":"Harris ST, Reginster JY, Harley C, et al. Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study. Bone. 2009;44:758\u201365.","journal-title":"Bone"},{"key":"184_CR68","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1532-5415.2011.03372.x","volume":"59","author":"A Kragh","year":"2011","unstructured":"Kragh A, Elmstahl S, Atroshi I. Older adults\u2019 medication use 6 months before and after hip fracture: a population-based cohort study. J Am Geriatr Soc. 2011;59:863\u20138.","journal-title":"J Am Geriatr Soc"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-014-0184-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0184-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T16:37:25Z","timestamp":1716741445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-014-0184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1007\/s40266-014-0184-2","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}